IFT140单等位致病变异所致非典型常染色体显性多囊肾病的临床谱与预后
本研究为病例系列,纳入2,797例接受基因检测的ADPKD样表型欧洲个体中75例携带IFT140单等位pLoF变异者,来自61个家系,共41种不同变异。患者多表现为大而外生性肾囊肿,90.2%为Mayo影像分类2A,仅1例进展至肾衰竭,总体肾脏预后较好,但60岁以上者56.3% eGFR<60mL/min/1.73m²。
要点
- IFT140单等位pLoF变异可致非典型ADPKD,影像以Mayo 2A为主。
- 肾脏预后总体较好,但60岁以上者过半存在CKD 3期及以上。
- 男性与女性年龄校正eGFR存在显著差异(P<0.001)。
核心结论
- 携带IFT140单等位pLoF变异的个体易发生非典型ADPKD的肾囊肿,总体肾脏预后较好。
研究设计与样本
- 病例系列研究,纳入2,797例接受基因检测的ADPKD样表型欧洲个体中的75例携带IFT140 pLoF变异者。
主要发现
- 75例来自61个家系,检出41种不同的单等位pLoF IFT140变异,中位年龄56岁,女性占53.3%。
- 多数患者表现为大而外生性肾囊肿,中位肾脏总体积688mL(IQR 201-4,139),90.2%为Mayo影像分类2A。
- 50.7%的患者合并动脉高血压,诊断中位年龄59岁(IQR 29-73)。
- 仅1例在69岁进展至肾衰竭;60岁以上者56.3% eGFR<60mL/min/1.73m²。
- 男女年龄校正eGFR存在显著差异(P<0.001);在100kG中仅囊性肾病(ICD-10 Q61)与pLoF IFT140变异相关(P=2.9×10⁻⁹,OR=5.6,95%CI 3.3-9.2)。
关键数值与推荐
- IFT140单等位pLoF变异的估计遗传患病率在Genome Aggregation Database中为19.76/万(95%CI 18.8-20.7),在100,000 Genomes Project中为27.89/万(95%CI 23.8-31.9)。
临床怎么用
- 对ADPKD样表型但影像不典型(如Mayo 2A、囊肿少而大)者,可考虑IFT140基因检测。
- IFT140相关肾囊肿患者仍需监测血压和肾功能,尤其60岁以上者应关注eGFR下降。
局限性
- 回顾性研究;IFT140相关囊性肾病可能在年轻或轻症患者中未被诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Monoallelic predicted loss-of-function (pLoF) variants in IFT140 have recently been associated with an autosomal dominant polycystic kidney disease (ADPKD)-like phenotype. This study enhanced the characterization of this phenotype. STUDY DESIGN: Case series. SETTING & PARTICIPANTS: Seventy-five among 2,797 European individuals with ADPKD-like phenotypes who underwent genetic testing that revealed pLoF IFT140-variants. FINDINGS: The 75 individuals (median age 56 years, 53.3% females) were from 61 families and were found to have 41 different monoallelic pLoF IFT140-variants. The majority of individuals presented with large, exophytic kidney cysts (median total kidney volume, 688mL [IQR, 201-4,139]), and 90.2% were classified using the Mayo Imaging Classification as Mayo Class 2A. Arterial hypertension was present in 50.7% of the individuals (median age at diagnosis, 59 years [IQR, 29-73]). Only 1 patient developed kidney failure (at age 69 years). A significant difference was observed in the age-adjusted estimated glomerular filtration rate (eGFR) between the male and female patients (P<0.001), and 56.3% of the individuals over the age of 60 years had an eGFR of<60mL/min/1.73m2. The estimated genetic prevalence of monoallelic pLoF IFT140 variants was 19.76 (95% CI, 18.8-20.7) and 27.89 (95% CI, 23.8-31.9) per 10,000 in the Genome Aggregation Database and the 100,000 Genomes Project (100kG), respectively. Only cystic kidney disease (ICD-10 Q61) was associated with pLoF IFT140 variants (P = 2.9 × 10-9, odds ratio = 5.6 (95% CI, 3.3-9.2) in 100kG. STUDY LIMITATIONS: Retrospective study; IFT140-related cystic kidney disease may not be diagnosed in younger patients or patients with milder forms. CONCLUSIONS: Individuals with monoallelic IFT140 pLoF variants are likely to develop kidney cysts atypical of classic ADPKD and generally have a favorable kidney prognosis. PLAIN-LANGUAGE SUMMARY: Monoallelic pathogenic variants in IFT140 have been linked to a spectrum of kidney disease clinically similar to autosomal dominant polycystic kidney disease (ADPKD). This article describes a case series of 75 individuals with ADPKD-IFT140. Affected individuals typically presented with an atypical imaging pattern, had fewer but larger kidney cysts compared with classic ADPKD, and rarely developed liver cysts. Although the kidney prognosis appeared better than in classic ADPKD, 56.3% of individuals over 60 years of age had stage 3 or more severe CKD. Individuals with ADPKD-IFT140 variants are likely to develop kidney cyst patterns atypical of ADPKD. Their kidney prognosis appears favorable.
引用
- Zagorec N, Calamel A, Delaporte M, et al. Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140. Am J Kidney Dis. 2024. PMID: 39732359. doi:10.1053/j.ajkd.2024.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。